| 1 | EAACI guidelines on the management of IgE‐mediated food allergy | 9.5 | 65 | Citations (PDF) |
| 2 | Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and <scp>nonallergic</scp> children | 9.5 | 17 | Citations (PDF) |
| 3 | Nutrition in chronic inflammatory conditions: Bypassing the mucosal block for micronutrients | 9.5 | 36 | Citations (PDF) |
| 4 | Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology | 9.5 | 20 | Citations (PDF) |
| 5 | Systematic review of the association between short‐chain fatty acids and allergic diseases | 9.5 | 55 | Citations (PDF) |
| 6 | Association between gut microbiota development and allergy in infants born during pandemic‐related social distancing restrictions | 9.5 | 32 | Citations (PDF) |
| 7 | A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report | 3.2 | 5 | Citations (PDF) |
| 8 | The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis | 12.7 | 72 | Citations (PDF) |
| 9 | Emergence of rifampicin-resistant staphylococci on the skin and nose of rifampicin-treated patients with an orthopaedic-device-related infection | 2.6 | 1 | Citations (PDF) |
| 10 | Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration | 9.5 | 23 | Citations (PDF) |
| 11 | Maternal allergy‐preventive diet index, offspring infant diet diversity, and childhood allergic diseases | 9.5 | 9 | Citations (PDF) |
| 12 | Ultra‐processed foods, allergy outcomes and underlying mechanisms in children: An EAACI task force report | 2.8 | 23 | Citations (PDF) |
| 13 | The epithelial barrier theory and its associated diseases | 9.5 | 85 | Citations (PDF) |
| 14 | The influence of lifestyle and environmental factors on host resilience through a homeostatic skin microbiota: An <scp>EAACI</scp> Task Force Report | 9.5 | 21 | Citations (PDF) |
| 15 | The immune‐supportive diet in allergy management: A narrative review and proposal | 9.5 | 32 | Citations (PDF) |
| 16 | Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19 | 13.9 | 48 | Citations (PDF) |
| 17 | An update on recent developments and highlights in food allergy | 9.5 | 23 | Citations (PDF) |
| 18 | Disrupted epithelial permeability as a predictor of severe <scp>COVID</scp>‐19 development | 9.5 | 10 | Citations (PDF) |
| 19 | Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An <scp>EAACI</scp> position paper | 9.5 | 201 | Citations (PDF) |
| 20 | Atopic outcomes at 2 years in the <scp>CORAL</scp> cohort, born in <scp>COVID</scp>‐19 lockdown | 2.8 | 9 | Citations (PDF) |
| 21 | Environment‐dependent alterations of immune mediators in urban and rural South African children with atopic dermatitis | 9.5 | 23 | Citations (PDF) |
| 22 | The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study | 9.5 | 85 | Citations (PDF) |
| 23 | EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old | 9.5 | 35 | Citations (PDF) |
| 24 | Cellular and molecular mechanisms of allergic asthma | 9.6 | 187 | Citations (PDF) |
| 25 | Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: A systematic review and meta‐analysis | 9.5 | 64 | Citations (PDF) |
| 26 | Microbiome-immune interactions and relationship to asthma severity | 6.2 | 12 | Citations (PDF) |
| 27 | Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19 | 9.5 | 16 | Citations (PDF) |
| 28 | Allergy‐related outcomes at 12 months in the CORAL birth cohort of Irish children born during the first COVID 19 lockdown | 2.8 | 20 | Citations (PDF) |
| 29 | Associations between child filaggrin mutations and maternal diet with the development of allergic diseases in children | 2.8 | 10 | Citations (PDF) |
| 30 | Parenting a newborn baby during the COVID-19 pandemic: a qualitative survey | 1.8 | 7 | Citations (PDF) |
| 31 | A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2 | 10.4 | 65 | Citations (PDF) |
| 32 | Role of dietary fiber in promoting immune health—An <scp>EAACI</scp> position paper | 9.5 | 99 | Citations (PDF) |
| 33 | Immunomodulation by foods and microbes: Unravelling the molecular tango | 9.5 | 31 | Citations (PDF) |
| 34 | Environmental influences on childhood asthma—The effect of diet and microbiome on asthma | 2.8 | 25 | Citations (PDF) |
| 35 | EAACI Biologicals Guidelines—Recommendations for severe asthma | 9.5 | 239 | Citations (PDF) |
| 36 | COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper | 9.5 | 87 | Citations (PDF) |
| 37 | ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) | 9.5 | 63 | Citations (PDF) |
| 38 | Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines | 9.5 | 52 | Citations (PDF) |
| 39 | Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines | 9.5 | 85 | Citations (PDF) |
| 40 | Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma | 9.5 | 18 | Citations (PDF) |
| 41 | An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism | 2.9 | 39 | Citations (PDF) |
| 42 | Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines | 9.5 | 113 | Citations (PDF) |
| 43 | EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update) | 2.8 | 350 | Citations (PDF) |
| 44 | Mechanisms of microbe-immune system dialogue within the skin | 3.8 | 79 | Citations (PDF) |
| 45 | Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives | 9.5 | 96 | Citations (PDF) |
| 46 | ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy | 3.2 | 45 | Citations (PDF) |
| 47 | Long‐term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS‐CoV‐2 infection | 9.5 | 26 | Citations (PDF) |
| 48 | ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper | 9.5 | 71 | Citations (PDF) |
| 49 | Spermidine and spermine exert protective effects within the lung | 2.3 | 47 | Citations (PDF) |
| 50 | IL‐10 induces IgG4 production in NOD‐<i>scid</i> Il2rγ<sup>null</sup> mice humanized by engraftment of peripheral blood mononuclear cells | 9.5 | 10 | Citations (PDF) |
| 51 | COVID‐19 pandemic and allergen immunotherapy—an EAACI survey | 9.5 | 35 | Citations (PDF) |
| 52 | Fracture biomechanics influence local and systemic immune responses in a murine fracture-related infection model | 1.2 | 13 | Citations (PDF) |
| 53 | Examining Associations Between Dietary Inflammatory Index in Pregnancy, Pro-inflammatory Cytokine and Chemokine Levels at Birth, and Offspring Asthma and/or Wheeze by Age 4 Years | 1.6 | 15 | Citations (PDF) |
| 54 | Advanced glycation end product intake during pregnancy and offspring allergy outcomes: A Prospective cohort study | 2.5 | 18 | Citations (PDF) |
| 55 | Early-Life Respiratory Infections in Infants with Cow’s Milk Allergy: An Expert Opinion on the Available Evidence and Recommendations for Future Research | 4.7 | 9 | Citations (PDF) |
| 56 | Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice | 3.8 | 46 | Citations (PDF) |
| 57 | Overview of in vivo and ex vivo endpoints in murine food allergy models: Suitable for evaluation of the sensitizing capacity of novel proteins? | 9.5 | 55 | Citations (PDF) |
| 58 | EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma | 9.5 | 129 | Citations (PDF) |
| 59 | Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma | 9.5 | 208 | Citations (PDF) |
| 60 | Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 | 9.5 | 969 | Citations (PDF) |
| 61 | Dietary factors during pregnancy and atopic outcomes in childhood: A systematic review from the European Academy of Allergy and Clinical Immunology | 2.8 | 143 | Citations (PDF) |
| 62 | A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2 | 9.5 | 107 | Citations (PDF) |
| 63 | COST Action ‘ImpARAS’: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium | 3.2 | 29 | Citations (PDF) |
| 64 | Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors | 9.5 | 484 | Citations (PDF) |
| 65 | Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement | 9.5 | 120 | Citations (PDF) |
| 66 | Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI) | 9.5 | 148 | Citations (PDF) |
| 67 | The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy | 9.5 | 3 | Citations (PDF) |
| 68 | Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement | 9.5 | 92 | Citations (PDF) |
| 69 | Prioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research — The European Strategic Forum on Allergic Diseases | 0.3 | 0 | Citations (PDF) |
| 70 | Recent developments and highlights in food allergy | 9.5 | 92 | Citations (PDF) |
| 71 | Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care | 9.5 | 91 | Citations (PDF) |
| 72 | Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases | 9.5 | 52 | Citations (PDF) |
| 73 | EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis | 9.5 | 139 | Citations (PDF) |
| 74 | The importance of social networks—An ecological and evolutionary framework to explain the role of microbes in the aetiology of allergy and asthma | 9.5 | 27 | Citations (PDF) |
| 75 | Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid | 6.2 | 166 | Citations (PDF) |
| 76 | Microbiome and skin biology | 2.4 | 82 | Citations (PDF) |
| 77 | Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients | 13.9 | 188 | Citations (PDF) |
| 78 | Bacterial secretion of histamine within the gut influences immune responses within the lung | 9.5 | 83 | Citations (PDF) |
| 79 | AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper | 9.5 | 22 | Citations (PDF) |
| 80 | High levels of butyrate and propionate in early life are associated with protection against atopy | 9.5 | 442 | Citations (PDF) |
| 81 | Much ado about Biologicals: <i>Highlights of the Master Class on Biologicals, Prague, 2018</i> | 9.5 | 2 | Citations (PDF) |
| 82 | Mechanisms of food allergy | 6.2 | 283 | Citations (PDF) |
| 83 | Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients | 6.2 | 236 | Citations (PDF) |
| 84 | Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis | 6.2 | 50 | Citations (PDF) |
| 85 | Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications | 9.5 | 88 | Citations (PDF) |
| 86 | AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer | 9.5 | 68 | Citations (PDF) |
| 87 | Recent developments and highlights in mechanisms of allergic diseases: Microbiome | 9.5 | 107 | Citations (PDF) |
| 88 | Microbiome and asthma | 2.6 | 136 | Citations (PDF) |
| 89 | Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis | 9.5 | 374 | Citations (PDF) |
| 90 | The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology | 6.2 | 313 | Citations (PDF) |
| 91 | Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma | 9.5 | 36 | Citations (PDF) |
| 92 | Histamine receptor 2 modifies iNKT cell activity within the inflamed lung | 9.5 | 40 | Citations (PDF) |
| 93 | Biology of the Microbiome 1 | 3.3 | 42 | Citations (PDF) |
| 94 | Immune regulation by histamine and histamine-secreting bacteria | 5.3 | 114 | Citations (PDF) |
| 95 | A wide diversity of bacteria from the human gut produces and degrades biogenic amines | 1.6 | 136 | Citations (PDF) |
| 96 | Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection | 3.9 | 199 | Citations (PDF) |
| 97 | Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™ | 2.4 | 89 | Citations (PDF) |
| 98 | Current challenges facing the assessment of the allergenic capacity of food allergens in animal models | 3.2 | 60 | Citations (PDF) |
| 99 | Microbiome–Host Immune System Interactions | 3.4 | 23 | Citations (PDF) |
| 100 | Histamine-secreting microbes are increased in the gut of adult asthma patients | 6.2 | 131 | Citations (PDF) |
| 101 | Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases | 6.2 | 822 | Citations (PDF) |
| 102 | The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local T
<sub>H</sub>
17 Responses | 3.5 | 165 | Citations (PDF) |
| 103 | Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease | 3.0 | 36 | Citations (PDF) |
| 104 | Potential Role of Gut Microbial Metabolites in Allergy Prevention in Children | 6.2 | 1 | Citations (PDF) |
| 105 | Innate mechanisms can predict successful allergy immunotherapy | 6.2 | 11 | Citations (PDF) |
| 106 | Monitoring immune responses in a mouse model of fracture fixation with and without Staphylococcus aureus osteomyelitis | 3.6 | 51 | Citations (PDF) |
| 107 | Host‐microbiome interactions in health and disease | 1.4 | 5 | Citations (PDF) |
| 108 | The use of animal models to discover immunological mechanisms underpinning sensitization to food allergens | 1.7 | 10 | Citations (PDF) |
| 109 | Influence of microbiome and diet on immune responses in food allergy models | 1.7 | 19 | Citations (PDF) |
| 110 | Human Dendritic Cell DC-SIGN and TLR-2 Mediate Complementary Immune Regulatory Activities in Response to Lactobacillus rhamnosus JB-1 | 2.4 | 33 | Citations (PDF) |
| 111 | Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants | 6.2 | 174 | Citations (PDF) |
| 112 | Prebiotics, probiotics, synbiotics, and the immune system | 2.3 | 225 | Citations (PDF) |
| 113 | Intestinal dendritic cells | 2.3 | 38 | Citations (PDF) |
| 114 | Consensus Communication on Early Peanut Introduction and the Prevention of Peanut Allergy in High-risk Infants | 4.7 | 26 | Citations (PDF) |
| 115 | Histamine receptor 2 is a key influence in immune responses to intestinal histamine-secreting microbes | 6.2 | 67 | Citations (PDF) |
| 116 | Salmonella Adhesion, Invasion and Cellular Immune Responses Are Differentially Affected by Iron Concentrations in a Combined In Vitro Gut Fermentation-Cell Model | 2.4 | 53 | Citations (PDF) |
| 117 | Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers | 2.6 | 40 | Citations (PDF) |
| 118 | Histamine receptor 2 modifies dendritic cell responses to microbial ligands | 6.2 | 118 | Citations (PDF) |
| 119 | <i><i>Bifidobacterium infantis</i></i>35624 modulates host inflammatory processes beyond the gut | 10.4 | 435 | Citations (PDF) |
| 120 | Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms | 2.4 | 85 | Citations (PDF) |
| 121 | <i>Bifidobacterium infantis</i>35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells | 21.2 | 272 | Citations (PDF) |
| 122 | Bifidobacterium Infantis 35624 Protects Against Salmonella -Induced Reductions in Digestive Enzyme Activity in Mice by Attenuation of the Host Inflammatory Response | 2.9 | 44 | Citations (PDF) |
| 123 | Research needs in allergy: an EAACI position paper, in collaboration with EFA | 3.2 | 150 | Citations (PDF) |
| 124 | Histamine regulation of innate and adaptive immunity | 6.0 | 40 | Citations (PDF) |
| 125 | Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases | 6.2 | 750 | Citations (PDF) |
| 126 | Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects | 6.2 | 60 | Citations (PDF) |
| 127 | The many routes of dendritic cells to ensure immune regulation | 6.2 | 15 | Citations (PDF) |
| 128 | Regulation of the immune response and inflammation by histamine and histamine receptors | 6.2 | 294 | Citations (PDF) |
| 129 | Immune system in the intestine and mucosal inflammation | 3.2 | 0 | Citations (PDF) |
| 130 | Impact of Administered <i>Bifidobacterium</i> on Murine Host Fatty Acid Composition | 1.4 | 75 | Citations (PDF) |
| 131 | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo | 2.5 | 40 | Citations (PDF) |
| 132 | Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohnʼs disease | 3.0 | 45 | Citations (PDF) |
| 133 | Technical Advance: Function and efficacy of an α4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis | 3.0 | 16 | Citations (PDF) |
| 134 | Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation? | 0.7 | 214 | Citations (PDF) |
| 135 | Novel immunotherapeutic approaches for allergy and asthma | 3.2 | 16 | Citations (PDF) |
| 136 | Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8 | 2.3 | 178 | Citations (PDF) |
| 137 | Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues | 4.9 | 180 | Citations (PDF) |
| 138 | Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer | 2.4 | 93 | Citations (PDF) |
| 139 | Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria | 2.5 | 54 | Citations (PDF) |
| 140 | Portrait of a canine probiotic Bifidobacterium—From gut to gut | 2.5 | 42 | Citations (PDF) |
| 141 | A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome | 2.3 | 234 | Citations (PDF) |
| 142 | 43 The Role of T Cells in Vagal Protection Against Intestinal Inflammation | 1.0 | 1 | Citations (PDF) |
| 143 | Mucosal cytokine imbalance in irritable bowel syndrome | 1.8 | 160 | Citations (PDF) |
| 144 | Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation | 4.4 | 341 | Citations (PDF) |
| 145 | Protective effects of <i>Lactobacillus reuteri</i> and <i>Bifidobacterium infantis</i> in murine models for colitis do not involve the vagus nerve | 2.4 | 66 | Citations (PDF) |
| 146 | Probiotic Effects on Inflammatory Bowel Disease1, | 3.0 | 141 | Citations (PDF) |
| 147 | <i>Salmonella typhimurium</i> stimulation combined with tumour-derived heat shock proteins induces potent dendritic cell anti-tumour responses in a murine model | 3.5 | 17 | Citations (PDF) |
| 148 | Effects of Lactobacillus salivarius 433118 on Intestinal Inflammation, Immunity Status and In vitro Colon Function in Two Mouse Models of Inflammatory Bowel Disease | 2.3 | 42 | Citations (PDF) |
| 149 | Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker? | 1.0 | 576 | Citations (PDF) |
| 150 | Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome | 0.7 | 776 | Citations (PDF) |
| 151 | Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans | 3.4 | 92 | Citations (PDF) |
| 152 | Functional modulation of human intestinal epithelial cell responses by <i>Bifidobacterium infantis </i>and <i>Lactobacillus salivarius</i> | 4.8 | 257 | Citations (PDF) |
| 153 | Comparative and Functional Analysis of Sortase-Dependent Proteins in the Predicted Secretome of
<i>Lactobacillus salivarius</i>
UCC118 | 3.5 | 152 | Citations (PDF) |
| 154 | Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles | 1.0 | 1,346 | Citations (PDF) |
| 155 | Mechanisms of adherence of a probioticLactobacillusstrain during and afterin vivoassessment in ulcerative colitis patients | 1.6 | 20 | Citations (PDF) |
| 156 | Influence of bifidobacterium infantis feeding on secretagogue response and gut barrier function in rats recovering from colitis | 1.0 | 2 | Citations (PDF) |
| 157 | Differential cytokine response of cells derived from different lymphoid compartments to commensal and pathogenic bacteria | 1.0 | 0 | Citations (PDF) |
| 158 | Probiotics by the parenteral route-efficacy in murine colitis and arthritis | 1.0 | 0 | Citations (PDF) |
| 159 | Diversity of epithelial cell gene expression in response to different lactobacilli | 1.0 | 0 | Citations (PDF) |
| 160 | Plasticity of epithelial cell cytokine responses to commensal and pathogenic species | 1.0 | 0 | Citations (PDF) |
| 161 | A Randomised Controlled Trial of a Probiotic Lactobacillus Strain in Healthy Adults: Assessment of its Delivery, Transit and Influence on Microbial Flora and Enteric Immunity | 1.6 | 42 | Citations (PDF) |
| 162 | In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings | 4.9 | 716 | Citations (PDF) |
| 163 | Probiotic human bifidobacteria: Selection of a new strain and evaluation in vitro and in vivo | 1.0 | 6 | Citations (PDF) |
| 164 | Immunologic response to a novel probiotic organism in patients with active Crohn's disease | 1.0 | 4 | Citations (PDF) |
| 165 | Probiotics, mononuclear cells, and epithelial cells: An anti-inflammatory network | 1.0 | 5 | Citations (PDF) |
| 166 | Title is missing! | 1.5 | 327 | Citations (PDF) |
| 167 | Impact of Long COVID on health and quality of life | 0.4 | 55 | Citations (PDF) |
